Best Practices for Fundraising and M&A Due Diligence
Demystifying M&A Valuation - Korean Version
Best Practices in Cannabis M&A
Negotiating Working Capital
New Innovations in Representations and Warranties Insurance to Accelerate Deals in 2021
Best Practices in M&A Due Diligence
What’s Hot and What’s Not in IO 2021?
Oncology venture funding, IPOs and partnerships have been exceptionally high in deal volume and values. Cancer continues to be the leading therapeutic area in the number and size of early deals, and the oncology pipeline continues to be a rich source of both follow-on agents as well as first-in-class programs.
Paradigm Changing Technologies in Oncology
Microbiome: Hope or Hype?
Demystifying Tech M&A Valuation
Maximizing M&A Value, Minimizing Risk: Business Process Integration - Part II
M&A Integration: Maximizing the Return on Technology and Talent